Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder

NCT00877487 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention-Deficit/Hyperactivity Disorder

Interventions

DRUG: SPD489 (Lisdexamfetamine dimesylate)
DRUG: Placebo

Sponsor

Shire